Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
주식 순위 #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
주가
$1.89
마지막 동기화: 2022-12-16
시가총액
$24.38M
변동 (1일)
8.62%
변동 (1년)
0.00%
국가
US
거래 Yumanity Therapeutics, Inc. (YMTX)

카테고리

Yumanity Therapeutics, Inc. (YMTX)의 주가 이력
최고 종가: $1.94 (2022-12-01 기준)

최저 종가: $18.35 (2020-12-01 기준)
Yumanity Therapeutics, Inc.의 주가 이력 (2020 ~ 2026)
연간 주가 성과
연도 성과
2022 -41.89%
2021 -81.82%
2020 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$551.16 41.05%
US
$163.88 487.17%
US
$1.03K 57.08%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH